Prostate Cancer Diagnostics Market Report

China Prostate Cancer Diagnostics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 26, 2023
  • PAGES：186
  • REPORT CODE：GMM1815649
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

    The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.

    This report elaborates on the current development of the Prostate Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Siemens Healthcare

    • Roche

    • OPKO

    • DiaSorin

    • Beckman Coulter

    • MDx Health

    • Ambry Genetics

    • Genomic Health

    • Abbott

    By Type:

    • Other

    • Biopsy

    • Tumor Biomarker Tests

    • Imaging

    By Application:

    • age 55-75

    • age > 75

    • age < 55

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Prostate Cancer Diagnostics Market Overview 2018-2029

    • 1.1 China Prostate Cancer Diagnostics Industry Development Overview

    • 1.2 China Prostate Cancer Diagnostics Industry Development History

    • 1.3 China Prostate Cancer Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Prostate Cancer Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Other (2018-2029)

      • 1.4.2 China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Biopsy (2018-2029)

      • 1.4.3 China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Tumor Biomarker Tests (2018-2029)

      • 1.4.4 China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Imaging (2018-2029)

    • 1.5 China Prostate Cancer Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age 55-75 (2018-2029)

      • 1.5.2 China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age > 75 (2018-2029)

      • 1.5.3 China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age < 55 (2018-2029)

    • 1.6 China Prostate Cancer Diagnostics Market Analysis by Region

      • 1.6.1 North China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Prostate Cancer Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Prostate Cancer Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Prostate Cancer Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Prostate Cancer Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Prostate Cancer Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Prostate Cancer Diagnostics Industry Development

    Chapter 3 Prostate Cancer DiagnosticsIndustry Chain Analysis

    • 3.1 Prostate Cancer Diagnostics Industry Chain

    • 3.2 Prostate Cancer Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Prostate Cancer Diagnostics Market

    • 3.3 Prostate Cancer Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Prostate Cancer Diagnostics Market

    Chapter 4 China Prostate Cancer Diagnostics Market, by Type

    • 4.1 China Prostate Cancer Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Prostate Cancer Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Prostate Cancer Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Prostate Cancer Diagnostics Production Volume and Growth Rate of Other

      • 4.5.2 China Prostate Cancer Diagnostics Production Volume and Growth Rate of Biopsy

      • 4.5.3 China Prostate Cancer Diagnostics Production Volume and Growth Rate of Tumor Biomarker Tests

      • 4.5.4 China Prostate Cancer Diagnostics Production Volume and Growth Rate of Imaging

    Chapter 5 China Prostate Cancer Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Prostate Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Prostate Cancer Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Prostate Cancer Diagnostics Market Size and Growth Rate of age 55-75

      • 5.5.2 China Prostate Cancer Diagnostics Market Size and Growth Rate of age > 75

      • 5.5.3 China Prostate Cancer Diagnostics Market Size and Growth Rate of age < 55

    Chapter 6 China Prostate Cancer Diagnostics Market, by Region

    • 6.1 China Prostate Cancer Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Prostate Cancer Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Prostate Cancer Diagnostics Market Analysis

    • 7.1 North China Prostate Cancer Diagnostics Market, by Type

    • 7.2 North China Prostate Cancer Diagnostics Market, by Application

    Chapter 8 Central China Prostate Cancer Diagnostics Market Analysis

    • 8.1 Central China Prostate Cancer Diagnostics Market, by Type

    • 8.2 Central China Prostate Cancer Diagnostics Market, by Application

    Chapter 9 South China Prostate Cancer Diagnostics Market Analysis

    • 9.1 South China Prostate Cancer Diagnostics Market, by Type

    • 9.2 South China Prostate Cancer Diagnostics Market, by Application

    Chapter 10 East China Prostate Cancer Diagnostics Market Analysis

    • 10.1 East China Prostate Cancer Diagnostics Market, by Type

    • 10.2 East China Prostate Cancer Diagnostics Market, by Application

    Chapter 11 Northeast China Prostate Cancer Diagnostics Market Analysis

    • 11.1 Northeast China Prostate Cancer Diagnostics Market, by Type

    • 11.2 Northeast China Prostate Cancer Diagnostics Market, by Application

    Chapter 12 Southwest China Prostate Cancer Diagnostics Market Analysis

    • 12.1 Southwest China Prostate Cancer Diagnostics Market, by Type

    • 12.2 Southwest China Prostate Cancer Diagnostics Market, by Application

    Chapter 13 Northwest China Prostate Cancer Diagnostics Market Analysis

    • 13.1 Northwest China Prostate Cancer Diagnostics Market, by Type

    • 13.2 Northwest China Prostate Cancer Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Siemens Healthcare

        • 14.1.1 Siemens Healthcare Company Profile

        • 14.1.2 Siemens Healthcare Prostate Cancer Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Roche

        • 14.2.1 Roche Company Profile

        • 14.2.2 Roche Prostate Cancer Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 OPKO

        • 14.3.1 OPKO Company Profile

        • 14.3.2 OPKO Prostate Cancer Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 DiaSorin

        • 14.4.1 DiaSorin Company Profile

        • 14.4.2 DiaSorin Prostate Cancer Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Beckman Coulter

        • 14.5.1 Beckman Coulter Company Profile

        • 14.5.2 Beckman Coulter Prostate Cancer Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 MDx Health

        • 14.6.1 MDx Health Company Profile

        • 14.6.2 MDx Health Prostate Cancer Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Ambry Genetics

        • 14.7.1 Ambry Genetics Company Profile

        • 14.7.2 Ambry Genetics Prostate Cancer Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Genomic Health

        • 14.8.1 Genomic Health Company Profile

        • 14.8.2 Genomic Health Prostate Cancer Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott

        • 14.9.1 Abbott Company Profile

        • 14.9.2 Abbott Prostate Cancer Diagnostics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Prostate Cancer Diagnostics Industry Research Conclusions

    • 15.2 Prostate Cancer Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Prostate Cancer Diagnostics Industry Market Size (2018-2029)

    • Figure China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Biopsy (2018-2029)

    • Figure China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Tumor Biomarker Tests (2018-2029)

    • Figure China Prostate Cancer Diagnostics Production Volume, Production Value and Growth Rate of Imaging (2018-2029)

    • Figure China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age 55-75 (2018-2029)

    • Figure China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age > 75 (2018-2029)

    • Figure China Prostate Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of age < 55 (2018-2029)

    • Figure North China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Prostate Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Prostate Cancer Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Prostate Cancer Diagnostics Market Share by Type in 2018

    • Figure China Prostate Cancer Diagnostics Market Share by Type in 2023

    • Figure China Prostate Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Volume and Growth Rate of Other (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Volume and Growth Rate of Biopsy (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Volume and Growth Rate of Tumor Biomarker Tests (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Volume and Growth Rate of Imaging (2018-2023)

    • Figure China Prostate Cancer Diagnostics Market Share by Application in 2018

    • Figure China Prostate Cancer Diagnostics Market Share by Application in 2023

    • Figure China Prostate Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Prostate Cancer Diagnostics Market Size and Growth Rate of age 55-75 (2018-2023)

    • Figure China Prostate Cancer Diagnostics Market Size and Growth Rate of age > 75 (2018-2023)

    • Figure China Prostate Cancer Diagnostics Market Size and Growth Rate of age < 55 (2018-2023)

    • Table China Prostate Cancer Diagnostics Production Volume by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Production Value by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Prostate Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Sales Volume by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Prostate Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Sales Value by Region (2018-2023)

    • Table China Prostate Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Prostate Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table North China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table South China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table East China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Prostate Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Prostate Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Prostate Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Prostate Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Siemens Healthcare Company Profile

    • Table Siemens Healthcare Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table OPKO Company Profile

    • Table OPKO Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table DiaSorin Company Profile

    • Table DiaSorin Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Beckman Coulter Company Profile

    • Table Beckman Coulter Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table MDx Health Company Profile

    • Table MDx Health Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Ambry Genetics Company Profile

    • Table Ambry Genetics Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Genomic Health Company Profile

    • Table Genomic Health Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Prostate Cancer Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US